Diabetes Severity Measured by Treatment Control Status and Number of Anti-diabetic Drugs Affects Presenteeism Among Workers With Type 2 Diabetes

Abstract

Background: The number of people with diabetes is increasing and resulting in major economic losses. Presenteeism accounts for the majority of economic losses, so measures against presenteeism are important. This study investigated the relationship between severity of type 2 diabetes and presenteeism.Methods: A cross-sectional study was conducted among workers over 40 years of age. Participants were classified as normal group or diabetic treatment group using their medical examination results and health insurance claims data. Diabetic treatment groups were described by degree of treatment control: Good (HbA1c <7%), Intermediate (7%≤ HbA1c <8%), and Poor (8%≤ HbA1c). Therapy type was also divided into monotherapy and combination therapy. Logistic regression analysis was performed to predict presenteeism loss using the Quantity and Quality method.Results: Data on 13271 workers were analyzed. Presenteeism loss was significantly higher in all treatment control groups compared with the normal group, particularly for the intermediate and poor control groups. The monotherapy group did not differ from the normal group, but presenteeism loss was significantly higher in the combination therapy group than the normal group.Conclusions: Presenteeism loss in workers with diabetes may be affected by diabetes severity, and even if treatment control was good, presenteeism loss could occur when the number of anti-diabetic drugs was high. Therefore, it is important to provide early intervention and continuous support as a preventive measure against not only diabetes and diabetes-related complications but also presenteeism.

Diabetes or calcium channel blocker contribute to cerebral hemodynamics after bypass surgery in adult patients with moyamoya disease

“…A patient was considered to have diabetes mellitus if they had a period discovery of plasma glucose level ≥11.1 mmol•L -1 , fasting blood glucose (FBG) ≥7.0 mmol•L -1 , or oral glucose resistance test (OGTT) 2 h glucose ≥11.1 mmol•L -1 . Hemoglobin A1c (HbA1c) was used to stage diabetes (12). For stage 1, HbA1c was 5.7-6.5%.…”